In the BioHarmony Drug Report Database
Doxercalciferol
Doxercalciferol, Hectorol (doxercalciferol) is a small molecule pharmaceutical. Doxercalciferol was first approved as Doxercalciferol on 1999-06-09. It is used to treat hyperparathyroidism in the USA. It is known to target vitamin D3 receptor and vitamin D 25-hydroxylase.
Trade Name
|
Doxercalciferol, Hectorol |
|---|---|
Common Name
|
doxercalciferol |
ChEMBL ID
|
CHEMBL1200810 |
Indication
|
hyperparathyroidism |
Drug Class
|
Vitamin D analogues |
Image (chem structure or protein)